Gomes-da-Silva, Lígia C <br/><br/>
Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells.  [electronic resource] 

 -  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V  Nov 2013 
 - 356-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-3441 
<br/><br/><label>Standard No.: </label>10.1016/j.ejpb.2013.04.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Cell Cycle Proteins--genetics<br/>Cell Death--genetics<br/>Cell Line, Tumor<br/>Cell Survival<br/>Endothelial Cells--metabolism<br/>G2 Phase Cell Cycle Checkpoints--genetics<br/>Gene Silencing<br/>Humans<br/>Inhibitory Concentration 50<br/>Liposomes<br/>Male<br/>Mitosis--genetics<br/>Paclitaxel--administration & dosage<br/>Prostatic Neoplasms--genetics<br/>Protein Serine-Threonine Kinases--genetics<br/>Proto-Oncogene Proteins--genetics<br/>RNA, Messenger--metabolism<br/>RNA, Small Interfering--administration & dosage<br/>Polo-Like Kinase 1